ViroSafety · Virus news
Hepatitis E latest news
Recent reports, outbreaks and research relating to Hepatitis E virus. Explore the latest stories from publishers around the world.
Latest updates
- An evidence synthesis commissioned by Iran's Ministry of Health recommends targeted hepatitis A vaccination for high-risk groups rather than universal routine childhood immunization.
- A Global Burden of Disease analysis found Egypt's liver cancer burden dropped during national hepatitis C elimination but rebounded after 2019 amid rising metabolic disease.
- Researchers found that endoplasmic reticulum stress triggered by hepatitis B virus causes the antiviral lectin CLEC18 to accumulate intracellularly rather than being secreted into circulation.
- Adding tenofovir amibufenamide to ongoing entecavir therapy achieved superior viral suppression and liver stiffness improvements compared to switching to monotherapy in patients with low-level hepatitis B viremia, though monotherapy better preserved renal function.
- A MASLD diagnosis increases the risk of hepatocellular carcinoma after hepatitis C cure, but less is known about the impact of steatosis grade and cardiometabolic burden.
- An observational study in Spanish emergency departments demonstrates that automated opt-out screening achieves significantly higher testing coverage and detects substantial numbers of previously undiagnosed hepatitis B and C infections compared to clinician-initiated testing.
- A comprehensive review reveals that HBx regulatory protein mutations in genotype D1 hepatitis B virus shift from flexible glycine substitutions in early infection to C-terminal truncations in liver cancer.
- CSIR-CCMB-led effort shapes national wastewater surveillance guidelines to monitor diverse pathogensCSIR-CCMB Hyderabad helped shape national wastewater surveillance guidelines to monitor diverse pathogens, boosting early outbreak detection and public health resilience.
- WHO fact sheet on sexually transmitted diseases (STIs), providing information on the scope of the problem, prevention, diagnosis, treatment, and WHO's work in this area.
- Drug-induced liver injury (DILI) is a diagnosis of exclusion that relies on a compatible temporal relationship between drug exposure and liver injury, the course after withdrawal of the suspecte…
- A review highlights that limited viral surveillance in Indonesia impedes the early detection of high-risk zoonotic pathogens despite significant ecological spillover drivers.
- Analyst rates Atea Pharmaceuticals a Buy: $13.50 fair value versus about $4.20; early-2027 C-FORWARD data could support a mid-2027 NDA if successful.
- Atea Pharmaceuticals (Nasdaq: AVIR) has entered into a credit facility agreement with Hercules Capital (NYSE: HTGC) for up to $200 million, according to a press release from the…
- A new Swiss study is a useful reminder that we are not counting a pork-borne virus that is almost certainly circulating here. On October 26, the
- A single-center retrospective observational study of 77 patients with neuralgic amyotrophy reveals that over half of focal hourglass-like nerve lesions directly contact crossing arterial vessels.
- Neuralgic amyotrophy (NA), also known as Parsonage-Turner Syndrome, is a multifocal inflammatory neuropathy primarily affecting the brachial and
- Plus: A summary of 2025 recalls in Switzerland
- A cross-sectional investigation in Warri, Nigeria, reveals significant correlations between hepatitis B e-antibodies and specific HIV envelope proteins among co-infected patients.
- A newly published editorial collection outlines computational breakthroughs developed by women researchers across metagenomics, quorum sensing, disease databases, and vaccine design while addressing systemic career disparities.
- A cross-sectional study of 323 HBsAg-positive inmates in Ghana found that 28.2% had markers of high HBV infectivity and 5.0% had markers of recent infection.
Headlines, summaries and images are supplied by the news feed. Select a story to read the original publisher’s article.

